TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422G907. A total of 4 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $84,666 | +4.6% | 10,300 | -1.9% | 0.00% | – |
| Q1 2024 | $80,955 | -79.2% | 10,500 | -75.8% | 0.00% | – |
| Q4 2023 | $389,267 | -23.9% | 43,300 | -24.3% | 0.00% | – |
| Q3 2023 | $511,368 | +31.1% | 57,200 | +125.2% | 0.00% | – |
| Q2 2023 | $390,144 | +3.2% | 25,400 | +62.8% | 0.00% | – |
| Q2 2022 | $378,000 | – | 15,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 15,000 | $370,000 | 0.00% |
| SIMPLEX TRADING, LLC | 19,800 | $487,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |